Forest Laborator is charged with defrauding the goverment
DoJ has charged Forest Laboratories with defrauding the government by illegally marketing the antidepressants Celexa and Lexapro for unapproved use in children and teenagers. Prosecutors charge former top executives at Forest with concealing a clinical study that showed that Celexa and Lexapro were not effective in children and might even pose risks, including causing some to become suicidal.
Amgen -biotechnology company -Massive Amgen Fraud Case
An unidentified whistleblower has filed a False Claims Act case against Amgen, the biotechnology company which makes arthritis and psoriasis drug Enbrel, and anti-anemia drug Aranesp. Amerisource-Bergen and online health-information provider WebMD Health Corp are also named. The case came out from under seal at a judge’s directive, and DoJ is still deciding if it will join. The case involves off-label marketing, kickbacks and Medicaid best price violations.
Johnson & Johnson and Scios are alleged in off-label marketing
The U.S. Justice Department has joined two whistleblower lawsuits alleging that Johnson & Johnson and Scios engaged in off-label marketing of the cardiac drug Natrecor.
GlaxoSmithKline has reserved $400 million to settle off-label and kick back chargesGlaxo’s $400 Million Reserve
GlaxoSmithKline has reserved $400 million to settle off-label and kick back charges related to “several products” sold from 1997 to 2004, including the antidepressant Wellbutrin. Glaxo said the reserve “reflects the current status of the [DoJ] investigation.”
1- Tenet Heathcare — $900,000,000 under the False Claims Act
2- HCA — $731,400,000 under the False Claims Act
3- Merck - $650,000 under the False Claims Act
4- HCA — $631,000,000 under the False Claims Act
5- Serono– $567,000,000 under the False Claims Act
6- TAP [Taketa-Abbott Pharmaceutical] Pharmaceutical Products Inc. — $559,483,560 under the False Claims Act
7- Schering Plough — $255,000,000 under the False Claims Act
8- Abbott Labs– $400,000,000 under the False Claims Act
9- Fresenius Medical Care of North America (National Medical Care) — $385,000,000 under the False Claims Act
10- Cephalon - $375,000,000 under the False Claims Act
11- Bristol Myers Squib — $328,000,000 under the False Claims Act
12- SmithKline Beecham Clinical Laboratories Inc. doing business as GlaxoSmith Kline — $325,000,000 under the False Claims Act
13- HealthSouth — $325,000,000 under the False Claims Act
14- National Medical Enterprises — $324,200,000 under the False Claims Act
15- Gambro Healthcare — $310,000,000 under the False Claims Act
16- Schering-Plough– $292,969,482 under the False Claims Act
17- AstraZeneca Pharmaceuticals — $266,127,844 under the False Claims Act
18- St. Barnabas Hospitals — $265,000,000 under the False Claims Act
19- Bayer Corporation — $257,200,000 under the False Claims Act
20- Schering-Plough — $255,000,000 under the False Claims Act
For more info read the Joint Effort Blog
Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
No comments: